Stock Track | Surgery Partners Plunges 23.55% in Pre-Market on Q4 Earnings Miss and Weak 2026 Outlook

Stock Track

Mar 03

Surgery Partners' stock experienced a significant pre-market plunge of 23.55% following the release of its fourth quarter 2025 financial results.

The sharp decline was primarily driven by a substantial earnings miss, with Q4 adjusted EPS of $0.12 falling significantly short of the analyst consensus estimate of $0.30. Additionally, the company reported Q4 adjusted EBITDA of $156.9 million, which missed estimates of $169.2 million, indicating margin pressure that impacted full-year performance according to company statements.

Adding to investor concerns, Surgery Partners provided 2026 revenue guidance in the range of $3.35 billion to $3.45 billion, which came in below the consensus estimate of $3.56 billion. While the company announced a $200 million share repurchase program and reported Q4 revenue that beat estimates, the profitability shortfalls and cautious outlook overshadowed these positive developments.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1124399670"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1124399670\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1124399670?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 17:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124399670","market":"nz","top_or_hot":-1,"title":"Stock Track | Surgery Partners Plunges 23.55% in Pre-Market on Q4 Earnings Miss and Weak 2026 Outlook","media":"Stock Track","content":"<p>Surgery Partners' stock experienced a significant pre-market plunge of 23.55% following the release of its fourth quarter 2025 financial results.</p><p>The sharp decline was primarily driven by a substantial earnings miss, with Q4 adjusted EPS of $0.12 falling significantly short of the analyst consensus estimate of $0.30. Additionally, the company reported Q4 adjusted EBITDA of $156.9 million, which missed estimates of $169.2 million, indicating margin pressure that impacted full-year performance according to company statements.</p><p>Adding to investor concerns, Surgery Partners provided 2026 revenue guidance in the range of $3.35 billion to $3.45 billion, which came in below the consensus estimate of $3.56 billion. While the company announced a $200 million share repurchase program and reported Q4 revenue that beat estimates, the profitability shortfalls and cautious outlook overshadowed these positive developments.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Surgery Partners Plunges 23.55% in Pre-Market on Q4 Earnings Miss and Weak 2026 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Surgery Partners Plunges 23.55% in Pre-Market on Q4 Earnings Miss and Weak 2026 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-03 17:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Surgery Partners' stock experienced a significant pre-market plunge of 23.55% following the release of its fourth quarter 2025 financial results.</p><p>The sharp decline was primarily driven by a substantial earnings miss, with Q4 adjusted EPS of $0.12 falling significantly short of the analyst consensus estimate of $0.30. Additionally, the company reported Q4 adjusted EBITDA of $156.9 million, which missed estimates of $169.2 million, indicating margin pressure that impacted full-year performance according to company statements.</p><p>Adding to investor concerns, Surgery Partners provided 2026 revenue guidance in the range of $3.35 billion to $3.45 billion, which came in below the consensus estimate of $3.56 billion. While the company announced a $200 million share repurchase program and reported Q4 revenue that beat estimates, the profitability shortfalls and cautious outlook overshadowed these positive developments.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SGRY","symbol_name":"Surgery Partners, Inc.","start_time":0,"source_url":"","article_id":"1124399670","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124399670","pubTimestamp":1772530251,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Surgery Partners' stock experienced a significant pre-market plunge of 23.55% following the release of its fourth quarter 2025 financial results.The sharp decline was primarily driven by a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SGRY":"Surgery Partners, Inc."},"translate_title":"个股追踪|Surgery Partners盘前暴跌23.55%，因第四季度盈利未达预期且2026年前景疲弱","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGRY":1},"content_text":"Surgery Partners' stock experienced a significant pre-market plunge of 23.55% following the release of its fourth quarter 2025 financial results.The sharp decline was primarily driven by a substantial earnings miss, with Q4 adjusted EPS of $0.12 falling significantly short of the analyst consensus estimate of $0.30. Additionally, the company reported Q4 adjusted EBITDA of $156.9 million, which missed estimates of $169.2 million, indicating margin pressure that impacted full-year performance according to company statements.Adding to investor concerns, Surgery Partners provided 2026 revenue guidance in the range of $3.35 billion to $3.45 billion, which came in below the consensus estimate of $3.56 billion. While the company announced a $200 million share repurchase program and reported Q4 revenue that beat estimates, the profitability shortfalls and cautious outlook overshadowed these positive developments.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}